Deals in brief
Medical devices industry deals in September 2019 total $2.15bn globally
Total medical devices industry deals for September 2019 worth $2.15bn were announced globally, according to GlobalData’s deals database.
The value marked a decrease of 18.5% over the previous month and a drop of 56% when compared with the last 12-month average of $4.89bn.
In terms of number of deals, the sector saw a rise of 4.1% over the last 12-month average with 127 deals against the average of 122 deals. In value terms, North America led the activity with deals worth $1.11bn.
Medical devices industry deals in September 2019: Top deals
The top five medical devices deals accounted for 68.9% of the overall value during September 2019.
The combined value of the top five medical devices deals stood at $1.48bn, against the overall value of $2.15bn recorded for the month.
The top five medical devices industry deals of September 2019 tracked by GlobalData were:
1) Stryker’s $500m acquisition of GYS Tech and Mobius Imaging
2) The $450m acquisition of EndoSpan by CryoLife
3) Cambridge Innovation Capital, Escala Capital Investments Cyprus, LGT Impact Ventures, Silk Road Fund and Watrium’s $242.67m venture financing of CMR Surgical
4) The $230m acquisition of Cheetah Medical by Baxter International
5) Aleph Venture Capital, Ansonia Holdings Singapore, Joy Capital and Samsung NEXT Ventures’ venture financing of Healthy io for $60m.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.
US medical devices industry sees 19% drop in deal activity in September 2019
The US medical devices industry saw a drop of 19% in overall deal activity during September 2019, when compared with the last 12-month average, according to GlobalData’s deals database. A total of 64 deals worth $1.11bn were announced in September 2019, compared to the 12-month average of 79 deals. Venture financing was the leading category in the month in terms of volume with 45 deals which accounted for 70.3% of all deals. In second place was M&A with 17 deals, followed by private equity with two transactions, respectively accounting for 26.6% and 3.1% of overall deal activity in the country’s medical devices industry during the month.
Medical device M&A deals in September 2019 total $1.26bn globally
Total medical devices industry M&A deals in September 2019 worth $1.26bn were announced globally, according to GlobalData’s deals database. The value marked a decrease of 31.8% over the previous month and a drop of 66.2% when compared with the last 12-month average, which stood at $3.72bn. North America held the top position in terms of volumen and value, with total announced deals in the period worth $768.94m. In 2019, as of the end of September 2019, medical devices M&A deals worth $31.59bn were announced globally, marking an increase of 39.8% year on year.
Dassault Systèmes completes acquisition of Medidata
Dassault Systèmes has completed its acquisition of Medidata Solutions, which will now operate as a Dassault Systèmes brand. Dassault Systèmes acquired all of the issued and outstanding common shares of Medidata for $92.25 per share in cash, representing a total value of approximately $5.8bn. Medidata ceased trading on NASDAQ as of the close of trading on 28 October 2019.
Abbott and Omada Health to offer personalised diabetes care
Abbott has partnered with Omada Health to provide personalised, on-the-go digital care and coaching for type 2 diabetes patients. Abbott’s continuous glucose monitoring system FreeStyle Libre will be combined with Omada Health’s digital care platform to create an integrated solution delivering real-time glucose data and actionable information for diabetes management.
3M closes $6.7bn acquisition of Acelity
US-based conglomerate 3M has completed the acquisition of wound care solutions provider Acelity and its KCI subsidiaries globally for around $6.7bn. The deal is part of 3M’s strategy to boost presence in advanced and surgical wound care. Acelity is a medical technology firm that offers advanced wound care and speciality surgical solutions under the KCI brand.